Related Experiment Video
Updated: Jul 4, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease
Mehmet Cakir1, Osman Cekiç, O Faruk Yilmaz
1Beyoğlu Eye Training and Research Hospital, Istanbul, Turkey. drmcakir@hotmail.com
Abstract:
We report a child with Coats disease who demonstrated a rapid response to intravitreal bevacizumab and triamcinolone injection. A 14-year-old boy presented with stage 3A Coats disease unresponsive to initial argon laser treatment and was injected with intravitreal bevacizumab and triamcinolone acetonide. Following intravitreal injection, a superior bullous exudative retinal detachment and subfoveal serous fluid collection dramatically improved. Additional argon laser photocoagulation resulted in complete regression of telangiectatic vessels as well as decrease in macular exudation. Visual acuity improved from 20/400 to 20/125 after treatment, and the boy remained stable 6 months after injection.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Diabetic Retinopathy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents